Endothelin Receptors Expressed by Immune Cells Are Involved in Modulation of Inflammation and in Fibrosis: Relevance to the Pathogenesis of Systemic Sclerosis

Tinazzi Elisa, Puccetti Antonio, Patuzzo Giuseppe, Barbieri Alessandro, Argentino Giuseppe, Confente Federico, Dolcino Marzia, Beri Ruggero, Marchi Giacomo, Ottria Andrea, Righetti Daniela, Rampudda Mariaelisa, Lunardi Claudio

Research output: Contribution to journalArticle

Abstract

Endothelin-1 (ET-1) plays a pivotal role in vasoconstriction, fibrosis, and inflammation, the key features of systemic sclerosis (SSc). ET-1 receptors (ETA and ETB) are expressed on endothelial cells, smooth muscle cells, and fibroblasts, but their presence on immune cells has not been deeply investigated so far. Endothelin receptors antagonists such as bosentan have beneficial effects on vasoconstriction and fibrosis, but less is known about their potential anti-inflammatory effects. We studied the expression of ET-1 receptors on immune cells (T and B lymphocytes, monocytes, and neutrophils) and the link between ET-1 and inflammation in patients with SSc. We show here that ET-1 exerts a proinflammatory effect in CD4+ T cells, since it induces an increased IFN-γ production; preincubation with antagonists of both receptors reduces IFN-γ production. Moreover, following ET-1 stimulation, neutrophils produce proinflammatory mediators, thus amplifying the effects of activated CD4+ T cells. Our data indicate that ET-1 system is involved in the pathogenesis of inflammation and fibrosis typical of SSc, through the activation of T lymphocytes and neutrophils and the consequent release of proinflammatory and profibrotic cytokines. These findings suggest that dual ET-1 receptors antagonist therapy, besides its effect on vasculopathy, has a profound impact on the immune system favouring antiinflammatory and antifibrogenic effects.

Original languageEnglish
Article number147616
JournalJournal of Immunology Research
Volume2015
DOIs
Publication statusPublished - 2015

Fingerprint

Endothelin Receptors
Systemic Scleroderma
Endothelin-1
Fibrosis
Endothelin A Receptors
Inflammation
T-Lymphocytes
Vasoconstriction
Neutrophils
Anti-Inflammatory Agents
Neutrophil Activation
Smooth Muscle Myocytes
Monocytes
Immune System
B-Lymphocytes
Endothelial Cells
Fibroblasts
Cytokines

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Endothelin Receptors Expressed by Immune Cells Are Involved in Modulation of Inflammation and in Fibrosis : Relevance to the Pathogenesis of Systemic Sclerosis. / Elisa, Tinazzi; Antonio, Puccetti; Giuseppe, Patuzzo; Alessandro, Barbieri; Giuseppe, Argentino; Federico, Confente; Marzia, Dolcino; Ruggero, Beri; Giacomo, Marchi; Andrea, Ottria; Daniela, Righetti; Mariaelisa, Rampudda; Claudio, Lunardi.

In: Journal of Immunology Research, Vol. 2015, 147616, 2015.

Research output: Contribution to journalArticle

Elisa, T, Antonio, P, Giuseppe, P, Alessandro, B, Giuseppe, A, Federico, C, Marzia, D, Ruggero, B, Giacomo, M, Andrea, O, Daniela, R, Mariaelisa, R & Claudio, L 2015, 'Endothelin Receptors Expressed by Immune Cells Are Involved in Modulation of Inflammation and in Fibrosis: Relevance to the Pathogenesis of Systemic Sclerosis', Journal of Immunology Research, vol. 2015, 147616. https://doi.org/10.1155/2015/147616
Elisa, Tinazzi ; Antonio, Puccetti ; Giuseppe, Patuzzo ; Alessandro, Barbieri ; Giuseppe, Argentino ; Federico, Confente ; Marzia, Dolcino ; Ruggero, Beri ; Giacomo, Marchi ; Andrea, Ottria ; Daniela, Righetti ; Mariaelisa, Rampudda ; Claudio, Lunardi. / Endothelin Receptors Expressed by Immune Cells Are Involved in Modulation of Inflammation and in Fibrosis : Relevance to the Pathogenesis of Systemic Sclerosis. In: Journal of Immunology Research. 2015 ; Vol. 2015.
@article{8ebfb1e4c8c1417a865ed47e45dce676,
title = "Endothelin Receptors Expressed by Immune Cells Are Involved in Modulation of Inflammation and in Fibrosis: Relevance to the Pathogenesis of Systemic Sclerosis",
abstract = "Endothelin-1 (ET-1) plays a pivotal role in vasoconstriction, fibrosis, and inflammation, the key features of systemic sclerosis (SSc). ET-1 receptors (ETA and ETB) are expressed on endothelial cells, smooth muscle cells, and fibroblasts, but their presence on immune cells has not been deeply investigated so far. Endothelin receptors antagonists such as bosentan have beneficial effects on vasoconstriction and fibrosis, but less is known about their potential anti-inflammatory effects. We studied the expression of ET-1 receptors on immune cells (T and B lymphocytes, monocytes, and neutrophils) and the link between ET-1 and inflammation in patients with SSc. We show here that ET-1 exerts a proinflammatory effect in CD4+ T cells, since it induces an increased IFN-γ production; preincubation with antagonists of both receptors reduces IFN-γ production. Moreover, following ET-1 stimulation, neutrophils produce proinflammatory mediators, thus amplifying the effects of activated CD4+ T cells. Our data indicate that ET-1 system is involved in the pathogenesis of inflammation and fibrosis typical of SSc, through the activation of T lymphocytes and neutrophils and the consequent release of proinflammatory and profibrotic cytokines. These findings suggest that dual ET-1 receptors antagonist therapy, besides its effect on vasculopathy, has a profound impact on the immune system favouring antiinflammatory and antifibrogenic effects.",
author = "Tinazzi Elisa and Puccetti Antonio and Patuzzo Giuseppe and Barbieri Alessandro and Argentino Giuseppe and Confente Federico and Dolcino Marzia and Beri Ruggero and Marchi Giacomo and Ottria Andrea and Righetti Daniela and Rampudda Mariaelisa and Lunardi Claudio",
year = "2015",
doi = "10.1155/2015/147616",
language = "English",
volume = "2015",
journal = "Journal of Immunology Research",
issn = "2314-8861",
publisher = "Hindawi Limited",

}

TY - JOUR

T1 - Endothelin Receptors Expressed by Immune Cells Are Involved in Modulation of Inflammation and in Fibrosis

T2 - Relevance to the Pathogenesis of Systemic Sclerosis

AU - Elisa, Tinazzi

AU - Antonio, Puccetti

AU - Giuseppe, Patuzzo

AU - Alessandro, Barbieri

AU - Giuseppe, Argentino

AU - Federico, Confente

AU - Marzia, Dolcino

AU - Ruggero, Beri

AU - Giacomo, Marchi

AU - Andrea, Ottria

AU - Daniela, Righetti

AU - Mariaelisa, Rampudda

AU - Claudio, Lunardi

PY - 2015

Y1 - 2015

N2 - Endothelin-1 (ET-1) plays a pivotal role in vasoconstriction, fibrosis, and inflammation, the key features of systemic sclerosis (SSc). ET-1 receptors (ETA and ETB) are expressed on endothelial cells, smooth muscle cells, and fibroblasts, but their presence on immune cells has not been deeply investigated so far. Endothelin receptors antagonists such as bosentan have beneficial effects on vasoconstriction and fibrosis, but less is known about their potential anti-inflammatory effects. We studied the expression of ET-1 receptors on immune cells (T and B lymphocytes, monocytes, and neutrophils) and the link between ET-1 and inflammation in patients with SSc. We show here that ET-1 exerts a proinflammatory effect in CD4+ T cells, since it induces an increased IFN-γ production; preincubation with antagonists of both receptors reduces IFN-γ production. Moreover, following ET-1 stimulation, neutrophils produce proinflammatory mediators, thus amplifying the effects of activated CD4+ T cells. Our data indicate that ET-1 system is involved in the pathogenesis of inflammation and fibrosis typical of SSc, through the activation of T lymphocytes and neutrophils and the consequent release of proinflammatory and profibrotic cytokines. These findings suggest that dual ET-1 receptors antagonist therapy, besides its effect on vasculopathy, has a profound impact on the immune system favouring antiinflammatory and antifibrogenic effects.

AB - Endothelin-1 (ET-1) plays a pivotal role in vasoconstriction, fibrosis, and inflammation, the key features of systemic sclerosis (SSc). ET-1 receptors (ETA and ETB) are expressed on endothelial cells, smooth muscle cells, and fibroblasts, but their presence on immune cells has not been deeply investigated so far. Endothelin receptors antagonists such as bosentan have beneficial effects on vasoconstriction and fibrosis, but less is known about their potential anti-inflammatory effects. We studied the expression of ET-1 receptors on immune cells (T and B lymphocytes, monocytes, and neutrophils) and the link between ET-1 and inflammation in patients with SSc. We show here that ET-1 exerts a proinflammatory effect in CD4+ T cells, since it induces an increased IFN-γ production; preincubation with antagonists of both receptors reduces IFN-γ production. Moreover, following ET-1 stimulation, neutrophils produce proinflammatory mediators, thus amplifying the effects of activated CD4+ T cells. Our data indicate that ET-1 system is involved in the pathogenesis of inflammation and fibrosis typical of SSc, through the activation of T lymphocytes and neutrophils and the consequent release of proinflammatory and profibrotic cytokines. These findings suggest that dual ET-1 receptors antagonist therapy, besides its effect on vasculopathy, has a profound impact on the immune system favouring antiinflammatory and antifibrogenic effects.

UR - http://www.scopus.com/inward/record.url?scp=84930965551&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930965551&partnerID=8YFLogxK

U2 - 10.1155/2015/147616

DO - 10.1155/2015/147616

M3 - Article

AN - SCOPUS:84930965551

VL - 2015

JO - Journal of Immunology Research

JF - Journal of Immunology Research

SN - 2314-8861

M1 - 147616

ER -